FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma

FDA Warns of Higher Death Risk With Pepaxto in Multiple Myeloma

The US Food and Drug Administration (FDA) has issued a safety alert regarding an increased risk of d...
read more
Paving the Way for Diversity in Clinical Trials

Paving the Way for Diversity in Clinical Trials

“I’m the first person in my circle of ...
read more
Study: Older multiple myeloma patients can be spared of long-term steroids

Study: Older multiple myeloma patients can be spared of long-term steroids

The combination of cancer therapy lenalidomide plu...
read more
Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

Cancer drug approved for NHS use in England gives some multiple myeloma patients another option

A drug has been made available on the NHS in Engla...
read more
Researchers discover how to prevent kidney damage in patients with multiple myeloma

Researchers discover how to prevent kidney damage in patients with multiple myeloma

Researchers at the University of Alabama at Birmin...
read more